Goetz et al. MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer. J Clin Oncol 35:3638-3646. Johnston S et al. MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer NPJ Breast Cancer...
1. Finn RS, Crown JP, Lang I, et al. The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanc...
Goetz et al. MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer. J Clin Oncol 35:3638-3646. Johnston S et al. MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer NPJ Breast Cancer. 2019 Jan 17;5:5. Verzenios Eu smPC. H...
HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study. Lancet Oncol. 2015 Jan;16(1):25-35. Epub 2014 Dec 16.
Legal entity responsible for the study: Pfizer Inc Funding: Pfizer Inc Disclosure: V. Diéras: Consulting and advisory role: Genentech, Lilly, Pfizer, AbbVie, Novartis Pharma KK, Roche-Peru. Speakers bureau: Pfizer, Novartis Pharma KK, Roche-Peru. N. Harbeck: Honoraria: Lilly, Novartis, Pfiz...
The aim of this qualitative descriptive exploratory study was to investigate the perception of nursing undergraduate students on the forms of expression of violence in the college environment. Data were collected using semi-structured in... ZA Pires Scherer,EA Scherer,P Tamaris Rossi,... - 《Revis...
2,169 Paloma Faith PLAYLISTS Trending Sunny Days by londonslonely Mellow Songs for Autumn Nights by molempire Remove ads the monster they made you by fellowshipofthefalls platinum No Words More Study by imy.hopkins Charmingly Antiquated by transientsamantha gem p r a y e r by pyuup...
aIn Study Two, however, the effect of a connected celebrity with high source credibility did not lead to a significantly different and higher intention to volunteer time and donate money. 在研究二,然而,一个连接的名人的作用以高来源可信度没有导致一个显着不同和更高的意图志愿时间和捐赠金钱。[tran...
英文标题:Effect of Amivantamab Dose Interruptions on Efficacy and Safety of First-line Amivantamab Plus Lazertinib in EGFR-mutant Advanced NSCLC:Exploratory Analyses from the MARIPOSA study 中文标题:MARIPOSA研究的探索性分析:埃万妥单抗中断对于埃万妥单抗+拉泽替尼一线治疗EGFR突变晚期NSCLC疗效和安全性的...
Johnston S et al. MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer NPJ Breast Cancer. 2019 Jan 17;5:5. Verzenios Eu smPC. Hortobagyi G, et al. Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer. N Engl J Med....